The Use of Recombinant Human Bone Morphogenetic Protein-2 in Revision Reverse Shoulder Arthroplasty with Glenoid Bone Loss on Secondary Revision Surgery Rates with Minimum 2-Year Follow-Up
The Use of Recombinant Human Bone Morphogenetic Protein-2 in Revision Reverse Shoulder Arthroplasty with Glenoid Bone Loss on Secondary Revision Surgery Rates with Minimum 2-Year Follow-Up. // Journal of Shoulder and Elbow Arthroplasty. – URL: https://www.sciencedirect.com/science/article/pii/S2471549226001267?dgcid=rss_sd_all
The Use of Recombinant Human Bone Morphogenetic Protein-2 in Revision Reverse Shoulder Arthroplasty with Glenoid Bone Loss on Secondary Revision Surgery Rates with Minimum 2-Year Follow-Up. Journal of Shoulder and Elbow Arthroplasty. https://www.sciencedirect.com/science/article/pii/S2471549226001267?dgcid=rss_sd_all
“The Use of Recombinant Human Bone Morphogenetic Protein-2 in Revision Reverse Shoulder Arthroplasty with Glenoid Bone Loss on Secondary Revision Surgery Rates with Minimum 2-Year Follow-Up.” Journal of Shoulder and Elbow Arthroplasty.
@article{article117205,
title = {The Use of Recombinant Human Bone Morphogenetic Protein-2 in Revision Reverse Shoulder Arthroplasty with Glenoid Bone Loss on Secondary Revision Surgery Rates with Minimum 2-Year Follow-Up},
journal = {Journal of Shoulder and Elbow Arthroplasty},
url = {https://www.sciencedirect.com/science/article/pii/S2471549226001267?dgcid=rss_sd_all}
}